sponsored
PatientsVille.com Logo

PatientsVille

Fascia Side Effects Poll Results

Our Users Report - Have you experienced Fascia side effects?

9 user poll responses

Loading...

« go back

Fascia Common Side Effects

The most commonly reported Fascia side effects (click to view or check a box to report):

Vaginal Infection (1)
Urinary Tract Infection (1)
Graft Infection (1)

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Graft Infection (9)
Vaginal Infection (8)
Urinary Tract Infection (2)

➢ More

sponsored

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.


Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Some can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

Up-to-date List of Fascia Research Studies

Rank Status Study
1 Recruiting Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain
Conditions: Myofascial Pain Syndromes;   Myofascial Trigger Point;   Low Back Pain;   Lumbago
Interventions: Device: Radial Extracorporeal Shock Wave;   Device: Placebo
Outcome Measure: Evidence of pain relief by visual analogue scale (VAS) of radial extracorporeal shock waves in Myofascial pain syndrome in the lumbar and gluteal region compared to placebo
2 Unknown  Dose Response Effects of Cervical Spinal Manipulative Therapy (SMT) on Pressure Sensitivity of Myofascial Trigger Points
Conditions: Trigger Points, Myofascial;   Myofascial Trigger Points;   Myofascial Pain Syndrome
Intervention: Other: cervical spinal manipulative therapy
Outcome Measures: Change scores of the pressure algometry;   The perception by subjects as to whether they received a real treatment
3 Unknown  Traditional Acupuncture and Myofascial Trigger Point Dry Needling and Acupressure for Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Procedure: Traditional needle acupuncture;   Procedure: Myofascial trigger point dry needling;   Procedure: Myofascial trigger point acupressure
Outcome Measure:
4 Unknown  Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome
Conditions: Cervicobrachial Neuralgia;   Myofascial Pain Syndromes
Intervention: Drug: Botulinum toxin serotype A
Outcome Measures: Numerical pain rating;   Brief Pain Inventory;   Neck Disability Index;   Cervical range of motion;   Number of trigger points;   Postural exam;   Pain Diary and medications use;   Short Form (SF)-36
5 Not yet recruiting Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
Conditions: Myofascial Pain Syndromes;   Myofascial Trigger Point Pain;   Trigger Point Pain, Myofascial
Interventions: Drug: OnabotulinumtoxinA;   Drug: Placebo
Outcome Measures: efficacy;   Duration of effect;   quality of life;   bladder/bowel/sexual functions;   complications of therapy
6 Unknown  Effects of Myofascial Release on Pain, Disability and Electromyography of Erector Spinae in Chronic Low Back Pain
Conditions: Low Back Pain;   Disability;   Motor Activity;   Range of Motion
Interventions: Other: Myofascial treatment;   Other: Placebo
Outcome Measures: Lumbar Pain;   Disability;   Fear Avoidance Beliefs;   EMG Erector Spinae;   Lumbar ROM
7 Recruiting Using Saline for Myofascial Pain Syndromes (USAMPS)
Condition: Myofascial Pain Syndrome
Interventions: Drug: Lidocaine;   Drug: Triamcinolone Acetonide;   Drug: Saline
Outcome Measures: Change of Pain Intensity before and at two weeks after treatment;   Duration of Pain;   Change of Pain Intensity before and 2 - 5 minutes after treatment
8 Not yet recruiting Diagnosis and Management of Myofascial Pain Syndrome in Women With Mastectomies
Conditions: Breast Cancer;   Myofascial Trigger Point
Interventions: Other: Kinesiotherapy;   Other: Isquemic compression;   Other: High voltage electrical stimulation
Outcome Measures: Pain;   Quality of life;   Skin Temperature;   Posture
9 Not yet recruiting Effectiveness of Physical Therapy Treatments of Myofascial Trigger Points in Subjects With Neck Pain
Conditions: Neck Pain;   Myofascial Pain Syndrome
Interventions: Other: Kinesiotherapy;   Other: Ultrasound;   Other: Diadynamic currents
Outcome Measures: Pain;   Cervical range of motion;   Skin temperature;   Muscle activity
10 Not yet recruiting Radial Shock Wave and Acupuncture for Myofascial Pain
Condition: Myofascial Pain
Interventions: Device: Radial shock wave;   Device: Acupuncture
Outcome Measures: VAS for pain;   Pain threshold;   neck disability index;   patient global assessment
11 Recruiting Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain
Condition: Myofascial Pelviperineal Pain
Interventions: Drug: botulinum toxin A + ropivacaïne;   Drug: Ropivacaïne
Outcome Measures: Evolution of the PGI-I (Patient Global Impression of Improvement);   Evaluation of pain on digital scale (EN);   To assess the changing parameters of quality of life: global improvement score / treatment satisfaction assessed by digital scale, international pain scales (MPI, QDSA, QCD) / Beck and HAD score;   To assess the evolution of analgesics consumption (score MQS)
12 Unknown  Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
Condition: Face Pain
Interventions: Drug: lidocaine;   Drug: chemodenercation
Outcome Measure: clinical response
13 Not yet recruiting Botox for Treatment of TMJ Disorder With Bruxism
Conditions: Temporomandibular Joint Disorders;   Bruxism;   Temporomandibular Joint Dysfunction Syndrome;   Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint
Intervention: Drug: onabotulinumtoxinA
Outcome Measures: 50% reduction in pain;   25% increase in maximal opening at incisors
14 Recruiting Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain
Condition: Myofascial Pelvic Pain
Interventions: Drug: Intervention-Botulinum Toxin Type A;   Drug: placebo
Outcome Measures: To evaluate the change in patient-reported pelvic pain following pelvic floor injections of 200 units of Botox compared with 20cc of normal saline.;   To evaluate the change in patient-reported pelvic pain following Botox injections in conjunction with pelvic floor physical therapy compared to saline injections with physical therapy.
15 Recruiting Effects of Thai Massage on Patients With Wrist Extensor Muscles Latent Myofascial Trigger Points
Condition: Patients With Latent Myofascial Trigger Point
Intervention: Other: Thai massage
Outcome Measures: Pressure Pain Threshold as a measure by algometry;   Pain scores on visual analog scale;   Wrist Range of motion as a Measure by goniometer;   Grip strength as a measure by hand-held dynamometer;   Patient satisfaction level
16 Recruiting rTMS Effects in the Neuromodulation and Pain Threshold of Chronic Myofascial Pain Patients
Condition: Chronic Pain
Interventions: Device: rTMS;   Device: Sham rTMS
Outcome Measures: Pain threshold;   Cortical excitability parameters (MEP, ICF, CSP and SICI)
17 Recruiting Interstitial Cystitis: Elucidation of the Psychophysiologic and Autonomic Characteristics (ICEPAC) Study
Conditions: Interstitial Cystitis/Painful Bladder Syndrome;   Myofascial Pelvic Pain
Intervention: Drug: Bupivacaine
Outcome Measures: Interstitial Cystitis;   Myofascial Pelvic Pain;   Depression Symptoms;   Stress Symptoms
18 Unknown  Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel
Conditions: Muscular Atrophy;   Sprains;   Tendonitis
Interventions: Drug: Ibuprofen;   Drug: Profenid
Outcome Measures: Clinical study evaluating the efficacy and safety of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, contusions, tendinitis, or Myofascial compared to Profenid ® 25mg / g gel. ";   Clinical study evaluating the tolerability of Ibuprofen 50mg / g gel in the treatment of patients with muscle pain, joint, or pain caused by sprains, contusions, tendinitis, or Myofascial compared to Profenid ® 25mg / g gel. "
19 Recruiting Paraspinal Stimulation in Treating MPS
Condition: Clinical Study - RCT
Intervention: Procedure: DIMMST
Outcome Measures: Pain severity;   Pain threshold;   Sleep quality - how did you feel when you woke up;   Sleep quality - compared to your habitual sleep;   Sleep quality -last night
20 Unknown  Massage of the Low Back Muscles Assessed With Ultrasound Scanning
Condition: Myofascial Pain Syndrome
Interventions: Procedure: Specific massage for fascial release;   Other: Quiet non-instructed rest for 3 minutes
Outcome Measure: Thickness of lumbodorsal fascia determined by ultrasound imaging

Fascia Patient Forum